Related Experiment Videos
[Liver-targeted regenerative medicine].
Naoya Kobayashi1, Chen Yong, Noriaki Tanaka
1Department of Surgery, Okayama University Graduate School of Medicine and Dentistry, Okayama, Japan.
Nihon Geka Gakkai Zasshi
|September 18, 2004
Summary
Liver regenerative medicine explores various cell sources for treating liver failure. A novel system enables safe, cost-effective, and scalable human hepatocyte immortalization for therapeutic applications.
Area of Science:
- Hepatology
- Regenerative Medicine
- Stem Cell Biology
Context:
- Liver failure presents a significant unmet medical need, driving research into novel therapeutic strategies.
- Current research focuses on cell-based therapies for liver regeneration, exploring diverse cell types.
- Existing cell sources for liver regeneration include stem cells and hepatocyte cell lines.
Purpose:
- To review potential cell candidates for liver-targeted regenerative medicine.
- To introduce a Cre/loxP-based reversible immortalization system for human hepatocytes.
- To highlight the development of a safe, scalable, and cost-effective human hepatocyte cell line.
Summary:
- This review discusses various cell types investigated for liver regeneration, such as embryonic stem cells, somatic stem cells, and progenitor cells.
- A key focus is the Cre/loxP-based reversible immortalization technique for human hepatocytes.
- This technology facilitates the creation of a safe and readily available human hepatocyte cell line for therapeutic use.
Impact:
- Enables the establishment of a highly safe human hepatocyte cell line.
- Offers a cost-effective and scalable solution for generating therapeutic cells.
- Advances the field of liver regenerative medicine by providing a promising cell source.